ArticleContemporary clinical trials communications2019

Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial.

Myuri T Ruthirakuhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.